Phase 3 clinical trials
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
At the time the article was last revised Henry Knipe had no recorded disclosures.View Henry Knipe's current disclosures
Phase 3 clinical trials are the final hurdle to establishing a drug or experimental treatment is safe and effective. They are expensive and often long processes recruiting large numbers of individuals (e.g. 1,000 to 3,000). They are aimed at confirming Phase 2 findings (effectiveness and side-effects) as well as defining how effective this new treatment is compared to current management.